LONDON - Governments need to stockpile different sorts of flu drugs -- not just Roche Holding AG's Tamiflu -- to counter the danger of resistance in a pandemic triggered by bird flu, British experts said on Wednesday.
The warning could boost demand for GlaxoSmithKline Plc's inhaled medicine Relenza, which has been largely overlooked in favor of Roche's more convenient pill.
|
©REUTERS/Dadang Tri
|
An Indonesian pharmacy worker conducts research to produce Oseltamivir capsules, a local version of Tamiflu, at the country's Kimia Farma laboratory in Bandung, west Java, February 17, 2006.
|
Scientists analyzing the structure of a key flu virus protein found that both H5N1 and seasonal flu could develop resistance to Tamiflu, while still remaining highly susceptible to Relenza.